The most important financial indicators for the company Euro Pharmamed Srl - Unique Identification Number 33289178:
sales in 2023 was
2.054.346
euro, registering a net profit of
26.333
euro and having an average number of
8
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 10.8%, from 1.860.454 euro in the year 2022, to 2.054.346 euro in 2023.
The Net Profit increased by 22.667 euro, from 3.677 euro in 2022, to 26.333 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Euro Pharmamed Srl - CUI 33289178
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
18.150
15.927
13.225
4.891
3.990
4.079
58.881
46.381
36.039
38.145
Current Assets
17.315
28.427
26.340
6.181
169.802
346.171
426.681
318.970
541.913
490.340
Inventories
7.954
20.430
20.397
1.241
3.686
31.607
21.070
175
134.457
308.830
Receivables
9.025
7.951
5.187
3.951
165.610
311.902
402.943
317.113
404.463
131.693
Cash
336
46
756
988
506
2.661
2.668
1.682
2.992
49.816
Shareholders Funds
-3.651
-9.224
-20.176
-66.421
-61.866
-98.823
-38.104
-25.465
-21.867
4.532
Social Capital
45
45
45
88
90
89
87
85
85
85
Debts
40.014
54.484
60.013
77.493
235.658
449.073
523.666
390.816
599.818
523.952
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4646 - 4646"
CAEN Financial Year
4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
490.340 euro in 2023 which includes Inventories of
308.830 euro, Receivables of
131.693 euro and cash availability of
49.816 euro.
The company's Equity was valued at
4.532 euro, while total Liabilities amounted to
523.952 euro.
Equity increased by 26.333 euro, from -21.867 euro in 2022, to 4.532 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Euro Pharmamed Srl